Veerhealth Care Current Share Price | Veerhealth Care Stock Screener
VEERHEALTH
Pharmaceuticals
Veerhealth Care Current Stock Price Today
Live Share Price BSE
₹49.99
▲
0.11 (0.22%)
As of September 18, 2026, the live Veerhealth Care share price (BSE: VEERHEALTH) is ₹49.99, up 0.22% from the previous close, with shares trading between ₹47.99 and ₹50.90 in today's trading session, and a 52-week range of ₹16.96–₹50.94.
Browse VEERHEALTH income statement to support your investment research.
Use the Veerhealth Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Veerhealth Care Market Cap
₹99.94 Cr.
VEERHEALTH P/E Ratio (TTM)
64.91
Veerhealth Care P/B Ratio
4.36
EPS (TTM)
₹0.27
Dividend Yield
-
Debt to Equity
0.11
VEERHEALTH 52 Week High
₹50.94
Veerhealth Care 52 Week Low
₹16.96
Operating Margin
10.00%
Profit Margin
3.77%
VEERHEALTH Revenue (TTM)
₹53.00
EBITDA
₹4.00
Net Income
₹2.00
Total Assets
₹44.00
Total Equity
₹23.00
Veerhealth Care Current Share Price Chart
Track the current Veerhealth Care share price and stock price with an interactive chart. Analyse VEERHEALTH price trends, trading volume, historical performance, and volatility across different timeframes — the complete Veerhealth Care stock quote in one place.
Veerhealth Care Company Profile - Fundamental Screener
Screen Veerhealth Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VEERHEALTH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE882C01035
Veerhealth Care Balance Sheet Screener
Screen VEERHEALTH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 44 | 34 | 28 | 25 | 20 | 19 | 18 | 16 | 15 | 13 |
| Current Assets | 19 | 11 | 14 | 10 | 6 | 7 | 6 | 3 | 7 | 8 |
| Fixed Assets | 23 | 20 | 12 | 12 | 11 | 10 | 10 | 6 | 6 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 8 | 8 | 4 | 3 | 4 | 3 | 3 | 0 | 0 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 23 | 22 | 22 | 21 | 14 | 14 | 14 | 13 | 13 | 13 |
| Share Capital | 20 | 20 | 20 | 10 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 3 | 2 | 2 | 11 | 7 | 7 | 7 | 6 | 6 | 6 |
Veerhealth Care Income Statement Screener - Profit & Revenue Analysis
Screen Veerhealth Care income statement and profit fundamentals.
Analyze VEERHEALTH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Veerhealth Care share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 32 | 18 | 15 | 15 | 11 | 12 | 12 | 6 | 6 | 3 | 3 | 2 |
| Expenses | 49 | 30 | 16 | 13 | 13 | 10 | 11 | 11 | 6 | 5 | 2 | 2 | 2 |
| EBITDA | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 10.00% | 7.00% | 3.00% | 5.00% | 4.00% | -9.00% | 1.00% | 6.00% | 7.00% | -2.00% | -19.00% | -1.00% | -12.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 1 | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.80 | 0.27 | 0.20 | 0.21 | 1.52 | -0.11 | 0.55 | 0.46 | 0.23 | 0.20 | 0.03 | 0.00 | 0.01 |
Veerhealth Care Cash Flow Screener - Liquidity Fundamentals
Screen VEERHEALTH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 3 | -1 | 2 | 1 | 0 | 2 | 2 | 2 | 0 |
| Investing Activities | -8 | 0 | -2 | -1 | 0 | -2 | -2 | -3 | 0 | 0 |
| Financing Activities | 10 | -6 | 6 | 0 | -1 | 2 | 0 | 1 | -1 | 0 |
| Net Cash Flow | 1 | -3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Veerhealth Care Shareholding Pattern Screener
See Veerhealth Care shareholding pattern with promoter, FII, and DII holdings.
Check Veerhealth Care promoter holding and ownership changes for VEERHEALTH on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.50% | 31.91% | 31.50% | 31.50% | 31.50% | 31.50% | 30.41% | 30.41% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 54.27% | 53.97% | 58.35% | 57.92% | 56.97% | 55.12% | 60.05% | 59.25% |
| Other Holding | 14.23% | 14.12% | 10.15% | 10.58% | 11.53% | 13.38% | 9.54% | 10.33% |
| Shareholder Count | 10,027 | 9,315 | 11,390 | 11,011 | 10,846 | 10,455 | 10,991 | 10,255 |
Veerhealth Care Share Dividend Screener - Share Yield Analysis
Check Veerhealth Care dividend history with payout and yield data.
View Veerhealth Care dividend details including ex-dates and amounts for VEERHEALTH stock.
Veerhealth Care Stock Index Membership
See which indices include Veerhealth Care stock.
Check VEERHEALTH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Veerhealth Care Market Events Screener - Corporate Actions
Get Veerhealth Care corporate actions including splits, bonuses, and buybacks.
Check Veerhealth Care stock events that may affect VEERHEALTH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Annual General Meeting | NA | 6.61% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 7.42% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 2.13% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 7.24% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.31% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -17.87% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.86% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 15.31% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.02% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.66% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -1.25% |
| 2023-09-22 | 2023-09-22 | Bonus | 1:1 | 1.28% |
Veerhealth Care Competitors Screener - Peer Comparison
Screen VEERHEALTH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 445,676 | 36.70 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 246,089 | 83.50 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 182,729 | 85.09 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 112,648 | 24.00 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 110,029 | 32.73 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 105,035 | 94.45 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 96,855 | 30.03 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 95,927 | 25.45 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 94,711 | 16.86 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 93,870 | 44.91 | 14,636 | 14.85% | 1,938 | 34.16 |
Veerhealth Care Company Announcements - News Screener
Screen VEERHEALTH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-11 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-31 | Update Regarding Letter Sent To Shareholders | - |
| 2026-08-31 | Shareholder Meeting For 34Th Annual General Meeting For The Financial Year 2025-2026 | - |
| 2026-08-31 | Reg. 34 (1) Annual Report. | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-08-13 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-13 | Results- Financial Results For Quarter Ended June 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-05 | Board Meeting Intimation for Consideration And Approval Of Financials For Quarter Ended June 2026 | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-22 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |